First date in.
Data from 1st Cohort of Patients in Multiple Myeloma Clinical Trial
? First cohort of patients treated with multiple doses of PAT-SM6 in multiple myeloma clinical trial; no serious adverse events reported
? Early evidence that PAT-SM6 is active in patients with resistant, end-stage disease
? Second cohort of patients currently being recruited
data from 1st cohort of patients in multiple m
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.45M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 330704 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 5312414 | 5 |
View Market Depth
| Last trade - 10.49am 03/07/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable